Diagnostic Products Corporation Announces Quarterly Dividend
20 Januar 2006 - 12:17AM
Business Wire
Diagnostic Products Corporation (NYSE:DP) announced today the
declaration of a quarterly cash dividend of $.07 per share of
Common Stock payable February 15, 2006 to shareholders of record on
January 30, 2006. Founded in 1971, Diagnostic Products Corporation
(DPC) is a global leader dedicated exclusively to immunodiagnostic
testing. The Company's product menu includes over 75 immunoassays
for medically important substances and over 375 specific allergens
and allergy panels. DPC also designs and manufactures automated
laboratory instrumentation that provides fast, accurate results
while reducing labor and reagent costs. DPC sells its products to
hospitals, clinics and laboratories domestically and in over 100
countries.
Diagnostic Products (NYSE:DP)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Diagnostic Products (NYSE:DP)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
Echtzeit-Nachrichten über Diagnostic Products (New York Börse): 0 Nachrichtenartikel
Weitere Diagnostic Products Corporation News-Artikel